Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 0.6511 -0.0038 (-0.58%) Streaming Delayed Price Updated: 11:29 AM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 55,114 Open 0.6640 Bid (Size) 0.6507 (1) Ask (Size) 0.6520 (5) Prev. Close 0.6549 Today's Range 0.6510 - 0.6860 52wk Range 0.6452 - 2.605 Shares Outstanding 72,407,215 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 07, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From Kezar Life Sciences, Inc. Via Business Wire Performance YTD -31.46% -31.46% 1 Month -15.43% -15.43% 3 Month -27.05% -27.05% 6 Month -23.41% -23.41% 1 Year -73.96% -73.96% More News Read More KZR Stock Earnings: Kezar Life Sciences Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Kezar Life Sciences, Inc. Via Business Wire Analyst Expectations for Kezar Life Sciences's Future November 27, 2023 Via Benzinga Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 06, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) April 08, 2024 From Kezar Life Sciences, Inc. Via Business Wire From Pennies to Fortunes: 3 Stocks Set to Make Millionaires March 27, 2024 Via InvestorPlace Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026 March 16, 2024 Via InvestorPlace KZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023 March 14, 2024 Via InvestorPlace Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update March 14, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) March 08, 2024 From Kezar Life Sciences, Inc. Via Business Wire Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal March 02, 2024 Via Talk Markets Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference February 28, 2024 From Kezar Life Sciences, Inc. Via Business Wire Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis February 26, 2024 From Kezar Life Sciences, Inc. Via Business Wire 3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond February 25, 2024 Via InvestorPlace 3 Penny Stocks Poised for an Unbelievable 1,000% Jump February 02, 2024 Via InvestorPlace As Oversupply Deflates Lithium Bubble, IPO Market Keeps In High Spirits January 08, 2024 Via Benzinga Topics Initial Public Offering Exposures Securities Market Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth December 18, 2023 Via InvestorPlace Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update November 13, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) November 03, 2023 From Kezar Life Sciences, Inc. Via Business Wire 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis October 23, 2023 Via ACCESSWIRE Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 09, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer October 03, 2023 From Kezar Life Sciences, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 October 05, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
